Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI)

Historical Holders from Q3 2024 to Q3 2025

Symbol
SNTI on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
29,787,647
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
5,609,415
Holdings value
$7,909,282
% of all portfolios
0%
Number of holders
15
Number of buys
9
Number of sells
-7
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Celadon Partners SPV 24 45% +19.5% $24,127,994 +$6,529,394 13,404,441 +37.1% Celadon Partners SPV 24 29 Aug 2025
New Enterprise Associates 15, L.P. 14.5% $11,968,700 3,775,615 New Enterprise Associates 15, L.P. 06 Mar 2025
Nantahala Capital Management, LLC 8.12% -18.7% $7,037,400 +$5,422,973 2,220,000 +3.4% Nantahala Capital Management, LLC 31 Mar 2025
ARMISTICE CAPITAL, LLC 4.99% -50% $4,564,204 +$2,865,052 1,439,812 +1.7% Armistice Capital, LLC 31 Mar 2025
Nantahala Capital Partners Limited Partnership 1.9% -66.8% $1,592,925 +$637,170 502,500 +66.7% NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 31 Mar 2025

Institutional Holders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 5,609,415 $7,909,282 -$2,933,647 $1.41 15
2025 Q2 6,484,682 $13,682,488 +$1,724,635 $2.11 14
2025 Q1 5,663,433 $19,029,155 +$16,777,530 $3.36 14
2024 Q4 667,184 $2,341,958 -$330,207 $3.51 14
2024 Q3 763,984 $1,726,485 +$1,717,436 $2.26 12